These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 4708009)

  • 1. Treatment of muscular dystrophy.
    Fowler WM
    Arch Phys Med Rehabil; 1973 Jun; 54(6):281-3. PubMed ID: 4708009
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum enzyme lowering and other effects of diethylstilbestrol (DIES) in Duchenne's muscular dystrophy (DMD).
    Cohen L; Morgan J; Schulman S; Lawrence A
    J Lab Clin Med; 1971 Nov; 78(5):797-8. PubMed ID: 5128833
    [No Abstract]   [Full Text] [Related]  

  • 3. Acanthosis nigricans following diethylstilbestrol therapy. Occurrence in patients with childhood muscular dystrophy.
    Banuchi SR; Cohen L; Lorincz AL; Morgan J
    Arch Dermatol; 1974 Apr; 109(4):545-6. PubMed ID: 4819110
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapy of progressive muscular dystrophy].
    Beckmann R
    Med Klin; 1971 Aug; 66(32):1099. PubMed ID: 5562103
    [No Abstract]   [Full Text] [Related]  

  • 5. [A new supportive therapy of certain progressive muscular dystrophies].
    Schmitt J
    Cah Med; 1972 Oct; 13(13):969-76. PubMed ID: 4642894
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experience with and considerations on therapy of progressive muscular dystrophies].
    Beckmann R
    Hippokrates; 1968 Dec; 39(23):876-88. PubMed ID: 5718770
    [No Abstract]   [Full Text] [Related]  

  • 7. [Our experience in the treatment of progressive muscular dystrophy].
    Buscaino GA
    Acta Neurol (Napoli); 1966; 21(2):133-50. PubMed ID: 5961587
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic possibilities in progressive muscular dystrophy].
    Beckmann R; von Osten V
    Dtsch Med Wochenschr; 1966 Jan; 91(3):108-16. PubMed ID: 5901816
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapy and macroergic phosphoric compounds in Duchenne's progressive muscular dystrophy].
    Radu H; Stenzel K; Blücher G; Gödri I
    Neurol Psihiatr Neurochir; 1969; 14(5):435-42. PubMed ID: 5380160
    [No Abstract]   [Full Text] [Related]  

  • 10. [Duchenne muscular dystrophy. Effects of vitamin E administration on urinary luminescence].
    Pizarro M; Lissi E; Reyes J; Holmgren J
    Rev Med Chil; 1998 Oct; 126(10):1165-72. PubMed ID: 10030087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systolic time intervals in patients with progressive muscular dystrophy treated with sodium selenite and vitamin E.
    Airenne AL; Westermarck T
    Med Biol; 1984; 62(2):154. PubMed ID: 6471936
    [No Abstract]   [Full Text] [Related]  

  • 12. An approach to treatment trials in muscular dystrophy with particular reference to agents influencing free radical damage.
    Edwards RH; Jones DA; Jackson MJ
    Med Biol; 1984; 62(2):143-7. PubMed ID: 6471933
    [No Abstract]   [Full Text] [Related]  

  • 13. A study of electromyographic findings in patients with progressive muscular dystrophy during remetabolizing therapy.
    Buscaino GA; Caruso G
    Acta Neurol (Napoli); 1966; 21(1):33-45. PubMed ID: 4385733
    [No Abstract]   [Full Text] [Related]  

  • 14. A trial of selenium and vitamin E in boys with muscular dystrophy.
    Gamstorp I; Gustavson KH; Hellström O; Nordgren B
    J Child Neurol; 1986 Jul; 1(3):211-4. PubMed ID: 3298399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-tocohydroquinone and muscle dystrophy.
    HARRIS PL; MASON KE
    Am J Clin Nutr; 1956; 4(4):402-5; discussion, 405-7. PubMed ID: 13339712
    [No Abstract]   [Full Text] [Related]  

  • 16. Recording progressive muscular dystrophy by split-frame cinematography.
    SCHWARTZ RP; MASON KE; TINKER T
    Am J Phys Med; 1955 Feb; 34(1):183-4. PubMed ID: 14361689
    [No Abstract]   [Full Text] [Related]  

  • 17. [Results with tocopheryl phosphate and inositol therapy of Erb's progressive muscular dystrophy].
    BECKMANN R
    Dtsch Z Nervenheilkd; 1951; 167(1):17-30. PubMed ID: 14926441
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapeutic strategy for muscular dystrophies].
    Shin JH; Takeda S
    Brain Nerve; 2007 Apr; 59(4):415-24. PubMed ID: 17447528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A critical evaluation of therapy in muscular dystrophy.
    Dowben RM
    Tex Rep Biol Med; 1964 Dec; 22():Suppl 1:848-59. PubMed ID: 5318928
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatments for muscular dystrophy: increased treatment options for Duchenne and related muscular dystropies.
    Wells DJ
    Gene Ther; 2008 Aug; 15(15):1077-8. PubMed ID: 18528429
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.